Frederick R. Ueland

4.9k total citations
87 papers, 2.4k citations indexed

About

Frederick R. Ueland is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Frederick R. Ueland has authored 87 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Reproductive Medicine, 45 papers in Obstetrics and Gynecology and 19 papers in Surgery. Recurrent topics in Frederick R. Ueland's work include Ovarian cancer diagnosis and treatment (51 papers), Endometrial and Cervical Cancer Treatments (39 papers) and Endometriosis Research and Treatment (15 papers). Frederick R. Ueland is often cited by papers focused on Ovarian cancer diagnosis and treatment (51 papers), Endometrial and Cervical Cancer Treatments (39 papers) and Endometriosis Research and Treatment (15 papers). Frederick R. Ueland collaborates with scholars based in United States, Japan and Canada. Frederick R. Ueland's co-authors include John R. van Nagell, Christopher P. DeSimone, Richard J. Kryscio, Edward J. Pavlik, Paul D. DePriest, Jill Kolesar, Rachel W. Miller, J Górski, S. Goodrich and Iwona Podzielinski and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Frederick R. Ueland

87 papers receiving 2.3k citations

Peers

Countries citing papers authored by Frederick R. Ueland

Since Specialization

Citations

This map shows the geographic impact of Frederick R. Ueland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick R. Ueland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick R. Ueland more than expected).

Fields of papers citing papers by Frederick R. Ueland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick R. Ueland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick R. Ueland. The network helps show where Frederick R. Ueland may publish in the future.

Co-authorship network of co-authors of Frederick R. Ueland

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick R. Ueland. A scholar is included among the top collaborators of Frederick R. Ueland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick R. Ueland. Frederick R. Ueland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study 2025 ·Gynecologic Oncology ·Victoria Bae‐Jump, Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle, Michele C. Hayward, Joan L. Walker, Andrea R. Hagemann, Steven Waggoner, Roisin E. O’Cearbhaill, Megan McDonald, Mitchell I. Edelson, Paul DiSilvestro, (unknown), (unknown), Ramey D. Littell, Frederick R. Ueland, Heather A. Lankes, Carol Aghajanian	1
2	M1 macrophage-engineered vesicles have anti-cancer activity in ovarian cancer 2025 ·Cancer Nanotechnology ·Connie D. Cao, J. Robert McCorkle, Derek B. Allison, Donglin Yan, Kristen S. Hill, Lan Li, Rani Jayswal, (unknown), Charles S. Dietrich, Frederick R. Ueland, Christopher I. Richards, Jill Kolesar	1
3	Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study 2024 ·JCO Precision Oncology ·(unknown), Shulin Zhang, Nan Lin, (unknown), E Belcher, (unknown), Thèrése Bocklage, Rachel W. Miller, John L. Villano, Michael J. Cavnar, Joseph Kim, Susanne M. Arnold, Frederick R. Ueland, Jill Kolesar	1
4	Cisplatin encapsulated human macrophage-engineered vesicles for utilization in ovarian cancer treatment 2024 ·Gynecologic Oncology ·(unknown), Namrata Anand, Connie D. Cao, J. Robert McCorkle, Frederick R. Ueland, Christopher I. Richards, Jill Kolesar	1
5	Human macrophage-engineered vesicles for utilization in ovarian cancer treatment (179) 2023 ·Gynecologic Oncology ·(unknown), Abigail Anderson, Namrata Anand, J. Robert McCorkle, (unknown), Kristen S. Hill, Frederick R. Ueland, Christopher I. Richards, Jill Kolesar	2
6	Human macrophage-engineered vesicles for utilization in ovarian cancer treatment 2023 ·Frontiers in Oncology ·(unknown), Namrata Anand, Abigail Anderson, J. Robert McCorkle, (unknown), (unknown), (unknown), Kristen S. Hill, Frederick R. Ueland, Christopher I. Richards, Jill Kolesar	21
7	Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer 2023 ·Frontiers in Oncology ·Charles A. Kunos, Denise Fabian, (unknown), Lauren Baldwin, Charles S. Dietrich, Rachel W. Miller, Frederick R. Ueland	2
8	SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer 2023 ·International Journal of Molecular Sciences ·(unknown), Nan Lin, Frederick R. Ueland, Jill Kolesar	7
9	Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies 2023 ·Molecular Therapy — Oncolytics ·Ying Wei, (unknown), (unknown), (unknown), (unknown), Junfeng Shi, Kai Cheng, Dabao Wu, Rolf J. Craven, Yadi Wu, Olivier Thibault, Lauren Baldwin, Binhua P. Zhou, Ying Zhou, Weidong Zhao, Burton B. Yang, Frederick R. Ueland, Xiuwei H. Yang	13
10	Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer 2021 ·PLoS ONE ·J. Robert McCorkle, J Górski, Jinpeng Liu, (unknown), (unknown), Nan Lin, Chi Wang, Frederick R. Ueland, Jill Kolesar	18
11	A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study 2018 ·Gynecologic Oncology ·Bradley J. Monk, James Kauderer, Katherine Moxley, Albert J. Bonebrake, Summer Dewdney, Angeles Alvarez Secord, Frederick R. Ueland, Carolyn M. Johnston, Carol Aghajanian	65
12	Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer 2017 ·Gynecologic Oncology ·(unknown), Jeffrey Elder, Lauren Baldwin, Rachel W. Miller, (unknown), John R. van Nagell, (unknown), Dava West, Emily V. Dressler, (unknown), Frederick R. Ueland	9
13	Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer 2014 ·Journal of Oncology ·John Hoff, Lauren Baldwin, (unknown), Edward J. Pavlik, Rachel W. Miller, Christopher P. DeSimone, Frederick R. Ueland, T. C. Tucker, Richard J. Kryscio, John R. van Nagell	1
14	Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index 2014 ·Gynecologic Oncology ·Jeffrey Elder, Edward J. Pavlik, (unknown), Rachel W. Miller, Christopher P. DeSimone, John Hoff, (unknown), Richard J. Kryscio, John R. van Nagell, Frederick R. Ueland	28
15	Frequency and Disposition of Ovarian Abnormalities Followed With Serial Transvaginal Ultrasonography 2013 ·Obstetrics and Gynecology ·Edward J. Pavlik, Frederick R. Ueland, Rachel W. Miller, Jessalyn M. Ubellacker, Christopher P. DeSimone, Jeffrey Elder, John Hoff, Lauren Baldwin, Richard J. Kryscio, John R. van Nagell	68
16	Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass 2013 ·American Journal of Obstetrics and Gynecology ·Robert E. Bristow, Melissa Hodeib, Alan Smith, Daniel W. Chan, Zhen Zhang, Eric T. Fung, Krishnansu S. Tewari, Donald G. Munroe, Frederick R. Ueland	15
17	Ovarian cancer screening with annual transvaginal sonography 2007 ·Cancer ·John R. van Nagell, Paul D. DePriest, Frederick R. Ueland, Christopher P. DeSimone, Amy Cooper, John McDonald, Edward J. Pavlik, Richard J. Kryscio	147
18	The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus 2006 ·Gynecologic Oncology ·Christopher P. DeSimone, (unknown), Amy Cooper, Susan C. Modesitt, Paul D. DePriest, Frederick R. Ueland, Edward J. Pavlik, Richard J. Kryscio, John R. van Nagell	27
19	Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT 2003 ·Gynecologic Oncology ·(unknown), Shahin Shajahan, Chendil Damodaran, James L. Wilder, Joseph F. Pulliam, Eun Young Lee, Frederick R. Ueland, John R. van Nagell, Mansoor M. Ahmed, Subodh M. Lele	64
20	Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Therapy 2002 ·Gynecologic Oncology ·Jeanne M. Schilder, Amy Thompson, Paul D. DePriest, Frederick R. Ueland, Michael L. Cibull, Richard J. Kryscio, Susan C. Modesitt, Karen H. Lu, John P. Geisler, Robert V. Higgins, Paul M. Magtibay, David E. Cohn, Matthew A. Powell, Christina Chu, Frederick B. Stehman, J. van Nagell	179

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact